Challenging the CNS Targeting Potential of Systemically Administered Nanoemulsion Delivery Systems: a Case Study with Rapamycin-Containing Fish Oil Nanoemulsions in Mice
Related Experiment Video
Updated: Jan 22, 2026

Author Spotlight: Development and Evaluation of a Cationic Nanoemulsion-Encapsulated Retinoic Acid System for Mucosal Vaccination
Published on: February 23, 2024
Ekta Kadakia1, Pratiksha Harpude1, Neha Parayath1
1Department of Pharmaceutical Sciences, School of Pharmacy, Northeastern University, Boston, Massachusetts, 02115, USA.
Purpose:
Despite extensive preclinical investigations, in-vivo properties and formulation characteristics that improve CNS drug delivery following systemic dosing of nanoemulsions remain incompletely understood.
Methods:
The CNS targeting potential of systemically administered nanoemulsions was evaluated by formulating rapamycin containing fish oil nanoemulsions, and testing the combined effect of formulation characteristics such as the circulation half-life and particle size distribution, on CNS delivery of rapamycin containing fish oil nanoemulsions in mice.
Results:
Results generated with rapamycin nanoemulsions suggested that circulation half-life and particle size distribution did not impact the brain targeting efficiency of rapamycin containing fish oil nanoemulsions. Further, in the absence of any improvement in the systemic exposures of rapamycin, nanoemulsions did not outperform their aqueous counterpart with respect to the extent of CNS drug delivery.
Conclusions:
Our findings confirm that BBB penetration, which primarily depends on intrinsic drug-related properties, may not be significantly improved following encapsulation of drugs in nanoemulsions. Graphical Abstract The CNS targeting potential of systemically administered nanoemulsions was investigated by formulating various rapamycin containing fish oil nanoemulsions associated with different formulation characteristics such as the circulation half-life and particle size distribution. The targeting efficiency (TE) defined as the ratio of the brain exposures to the accompanying systemic exposures of rapamycin was estimated for each formulation following IV dosing in mice.
Insights
Nanoemulsions did not improve brain drug delivery of rapamycin, as formulation characteristics did not impact targeting efficiency. Encapsulation in nanoemulsions may not enhance blood-brain barrier penetration for drugs.
Area of Science:
- Pharmacology
- Nanotechnology
- Neuroscience
Background:
- Systemic administration of nanoemulsions is a strategy for enhancing drug delivery to the central nervous system (CNS).
- Understanding the in-vivo properties and formulation characteristics influencing CNS drug delivery of nanoemulsions is crucial but remains incomplete.
Purpose of the Study:
- To evaluate the CNS targeting potential of systemically administered nanoemulsions.
- To investigate the impact of formulation characteristics, such as circulation half-life and particle size, on CNS delivery of rapamycin-loaded nanoemulsions.
Main Methods:
- Rapamycin-loaded fish oil nanoemulsions were formulated and characterized.
- The effect of circulation half-life and particle size distribution on CNS delivery of nanoemulsions was assessed in mice.
- Targeting efficiency (TE) was calculated as the ratio of brain to systemic exposure of rapamycin after intravenous dosing.
Main Results:
- Circulation half-life and particle size distribution did not significantly affect the brain targeting efficiency of rapamycin nanoemulsions.
- Nanoemulsions did not demonstrate superior CNS drug delivery compared to their aqueous counterparts when systemic exposures were not improved.
- The blood-brain barrier (BBB) penetration of rapamycin was not enhanced by encapsulation in these nanoemulsions.
Conclusions:
- Blood-brain barrier penetration is primarily governed by intrinsic drug properties, not significantly improved by nanoemulsion encapsulation.
- Current nanoemulsion formulations may not be an effective strategy for enhancing CNS drug delivery for all drugs.
- Further research is needed to identify formulation strategies that can overcome BBB limitations for CNS drug delivery.
Related Concept Videos
Second Order systems II
First Order Systems
When a first-order system is subjected to a unit-step input, its response is characterized by its transfer function. By applying the Laplace transform of the unit-step input to the transfer function, expanding the...
Second Order systems I
By reinterpreting the system, one can derive the closed-loop transfer function, which...
Classification of Systems-I
Homogeneity dictates that if an input x(t) is multiplied by a constant c, the output y(t) is multiplied by the same constant. Mathematically, this is expressed as:
Classification of Systems-II
Mechanical Systems

